How Do You Fix A Broken Nail?
Discussion
Distal digits, especially of the hand, are important as they provide support for pinching and grip, give tactile sensation and contribute to cosmesis. Trauma to the distal digit and nailbed ranges from significant trauma with digital crush injuries or amputation to minor broken nails causing only annoyance. Most injuries especially in children involve the hand especially the middle finger. The dominant hand is more common if the child has a hand-preference. Usually they occur indoors especially being caused by being pinched by a door.
Significant trauma requires surgical intervention and may require specialty s...
Source: PediatricEducation.org - April 9, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Crescita Announces Launch of Pliaglis in U.S.
MISSISSAUGA, ON, March 29, 2018 -- (Healthcare Sales & Marketing Network) - Crescita Therapeutics Inc. (TSX: CTX) ("Crescita" or "the Company"), a commercial dermatology company with a portfolio of non-prescription skincare products an... Biopharmaceuticals, Dermatology, Product Launch Crescita Therapeutics, Pliaglis, lidocaine, tetracaine, dermal anaesthesia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2018 Category: Pharmaceuticals Source Type: news
Endo, others to pay $270.8 mln to resolve Lidoderm U.S. antitrust cases
(Reuters) - Endo International Plc and two other companies have agreed to pay $270.8 million to resolve class action lawsuits alleging Endo paid a generic drug manufacturer to delay launching a cheaper version of its Lidoderm painkiller patch. (Source: Reuters: Health)
Source: Reuters: Health - March 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
ZTLido (Lidocaine) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 7, 2018 Category: Drugs & Pharmacology Source Type: news
Lidocaine Patches for Somatic Back Pain Lidocaine Patches for Somatic Back Pain
Is there evidence demonstrating that lidocaine 5% patches are effective for relief of somatic back pain?American Family Physician (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Sorrento Therapeutics Subsidiary, Scilex, Receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ( “Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and Drug Administration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 28, 2018 Category: Drugs & Pharmacology Source Type: news
Sorrento Therapeutics wins FDA nod for post-shingles pain patch
Shares in Sorrento Therapeutics (NSDQ:SRNE) soared today after the company announced that the FDA approved its ZTlido lidocaine pain patch designed to treat patients with post-shingles neuralgia.
The company resubmitted its application for ZTlido to the FDA last year after it was rejected by the U.S. regulatory agency in 2016.
Get the full story at our sister site, Drug Delivery Business News.
The post Sorrento Therapeutics wins FDA nod for post-shingles pain patch appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 28, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Sorrento Therapeutics Source Type: news
Lidocaine Hydrochloride Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 20, 2018 Category: Drugs & Pharmacology Source Type: news
Efficacy of Articaine versus Lidocaine in Supplemental Infiltration for Mandibular First versus Second Molars with Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial
ConclusionsThe success rate for IANB with 4% articaine was 25%. Articaine and lidocaine had similar success rates for supplemental infiltration in first molars, whereas articaine was significantly more successful for second molars. However, because BI often did not provide profound pulpal anesthesia, additional techniques including intraosseous anesthesia may still be required. (Source: Dental Technology Blog)
Source: Dental Technology Blog - February 16, 2018 Category: Dentistry Source Type: news
CidalEaze (Lidocaine 3% HCL Cream) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 1, 2018 Category: Drugs & Pharmacology Source Type: news
Low-level laser therapy and anesthetic infiltration for orofacial pain in patients with fibromyalgia: a randomized clinical trial.
CONCLUSIONS:The LLLT by GaAlAs and anesthetic infiltration of lidocaine 2% were equally effective to control orofacial pain in FM individuals. (Source: Dental Technology Blog)
Source: Dental Technology Blog - December 29, 2017 Category: Dentistry Source Type: news
Case series: treating cannabinoid hyperemesis syndrome with capsaicin cream
3 out of 5 stars
Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Dezieck L et al. Clin Toxicol 2017 Sep;55:908-913.
Abstract
Cannabis hyperemesis syndrome (CHS) is a form of cyclic vomiting characterized by:
chronic marijuana use
recurrent vomiting, and
lack of alternate explanation for symptoms
A striking feature is that although CHS-induced nausea and vomiting are frequently resistant to standard antiemetics such as ondansetron, patients often report that very hot showers or baths relieve their symptoms. Several years ago, Jeff Lapoint noticed that the...
Source: The Poison Review - December 5, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical cannabinoid hyperemesis syndrome capsaicin treatment TRPV1 receptor Source Type: news
Scilex seeks EU nod for ZTlido lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that it filed a marketing authorization application seeking approval for its ZTlido lidocaine patch.
The San Diego, Calif.-based company said it is pursuing a hybrid regulatory pathway with the Medicines and Healthcare Products Regulatory Agency in the U.K., which will serve as the lead review agency. The company also plans to file for review in other countries, including Germany, France, Spain, Italy and Ireland.
Get the full story at our sister site, Drug Delivery Business News.
The post Scilex seeks EU nod for ZTlido lidocaine patch appe...
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Scilex Pharmaceuticals Sorrento Therapeutics Source Type: news
Ridge Properties DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of all lots of Naturally HL Bedsore Cream, Pretat by TAT Balm Carbomer Free Gel, & All Naturally HL Hemorrhoid products due to manufacturing concerns at the facility
Ridge Properties DBA Pain Relief Naturally voluntarily recalls all lots within expiry of Naturally HL Bedsore Relief Cream, Extra Strength PreTAT by TAT Balm Carbomer Free Gel and Extra Strength Naturally HL Hemorrhoid Numbing with Lidocaine. (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - November 9, 2017 Category: Complementary Medicine Authors: NCCIH Source Type: news
